Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study

Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study

Introduction: Thromboembolic events, including mainly pulmonary embolisms and ischemic strokes, occur in up to one-third of COVID-19 patients. As efficacy of tocilizumab (TCZ) among patients with acute pulmonary embolism (PE) was not previously investigated, this study aimed to provide such data. Ob...

Full description

Bibliographic Details
Main Authors: Daniel Chober, Bogusz Aksak-Wąs, Jolanta Niścigorska-Olsen, Małgorzata Niekrasz, Miłosz Parczewski
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
COVID-19
tocilizumab
embolism
thrombosis
mortality
Online Access:https://www.mdpi.com/2227-9059/10/7/1581

Internet

https://www.mdpi.com/2227-9059/10/7/1581

Similar Items